HomeNDC LookupIngredientsButenafine Hydrochloride › 11673-0436-01
🧴image loading
(from DailyMed)

Jock Itch Cream Butenafine Hydrochloride 10 mg/g Cream

by TARGET CORPORATION · 1 TUBE in 1 CARTON (11673-436-01) / 12 g in 1 TUBE
NDC 11673-0436-01
🏷️ FDA NDC (as labeled) 11673-436-01 billing pads the product segment with a zero
OTC Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 11673-436-01
Product NDC 11673-436
11-digit billing NDC 11673043601
RxCUI 1298448
UNII R8XA2029ZI
UPC 0311673436011
Application # ANDA205181
SPL Set ID 1d8a17ae-4e25-f591-e063-6394a90a35dd
Established class (EPC) Benzylamine Antifungal
Chemical class Benzylamines
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-11-15
Route TOPICAL
Dosage form CREAM
Substance BUTENAFINE HYDROCHLORIDE
Why two NDCs? The FDA registers this code as 11673-436-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 11673-0436-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Benzylamine Antifungal class.

Pharmacologic class Benzylamine Antifungal
Drug family (ATC) Other antifungals for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerTARGET CORPORATION
Application holderSUN PHARMA CANADA INC
FDA applicationANDA205181 (ANDA)
Labeler code11673
First marketedNov 2024
Product typeHuman Otc Drug
Portfolio407 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • Butenafine cream treats three common fungal skin infections: athlete's foot (between the toes), jock itch, and ringworm. It also helps relieve the itching, burning, cracking, and s...
  • What infections does butenafine cream actually treat?
  • You might notice your symptoms improving before you finish the full course, but it's really important to keep applying the cream as directed. For athlete's foot between the toes, y...
  • How long do I need to use it before it starts working?
📖 Read our full Butenafine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Athletes Foot 10 mg/g 70677-1269-01 STRATEGIC 1 tube $0.310 Availability likely
Athletes Foot 10 mg/g 00363-2100-02 Walgreen 1 tube FDA listed
Jock Itch 10 mg/g 00363-2101-08 Walgreen 1 tube FDA listed
Lotrimin Ultra 1 g/100g 11523-0082-01 Bayer 1 tube FDA listed
Lotrimin Ultra Ringworm 1 g/100g 11523-0158-02 Bayer 1 tube FDA listed
Lotrimin Ultra Athletes Foot 1 g/100g 11523-4338-01 Bayer 1 tube FDA listed
Lotrimin Ultra Jock Itch 1 g/100g 11523-4339-01 Bayer 1 tube FDA listed
Athletes Foot 10 mg/g 11673-0016-02 Target 1 tube FDA listed
Jock Itch Cream 10 mg/gthis 11673-0436-01 TARGET 1 tube FDA listed
Athletes Foot 10 mg/g 11822-2100-02 Rite 1 tube FDA listed
Butenafine Hydrochloride 10 mg/g 21130-0965-01 Albertsons 1 tube FDA listed
Butenafine Hydrochloride Athletes Foot 10 mg/g 30142-0210-02 Kroger 1 tube FDA listed
Athletes Foot 10 mg/g 36800-0049-01 TOPCO 1 tube FDA listed
Athletes Foot Ultra 10 mg/g 37808-0013-02 H 1 tube FDA listed
Butenafine Hydrochloride Jock Itch 10 mg/g 49035-0178-08 Wal-Mart 1 tube FDA listed
Athletes Foot Ultra 10 mg/g 49035-0225-08 Wal-Mart 1 tube FDA listed
Athletes Foot 10 mg/g 51672-2100-01 Sun 1 tube FDA listed
Jock Itch 10 mg/g 51672-2101-01 Sun 1 tube FDA listed
Athletes Foot 10 mg/g 69842-0986-02 CVS 1 tube FDA listed
Butenafine Hydrochloride 1% 10 mg/g 69842-0989-08 CVS 1 tube FDA listed
Butenafine Hydrochloride 10 mg/g 73581-0210-02 YYBA 1 tube FDA listed
Butenafine Hydrochloride 10 mg/g 79481-0086-01 MEIJER 1 tube FDA listed
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Nov 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic on the market
this product is a generic
This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Jock Itch Cream (this brand).

Top reported reactions

Aspartate Aminotransferase Increased4
Condition Aggravated4
Alanine Aminotransferase Increased3
Application Site Pain3
Blood Creatinine Increased3
Blood Lactate Dehydrogenase Increased2
Cerebral Infarction2

Reporter sex

60 reports

Serious outcomes

Death5
Life-threatening4
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 7 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
11673-0436-01 You're viewing this 1 TUBE in 1 CARTON (11673-436-01) / 12 g in 1 TUBE 2024-11-15 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 11673-436-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 11673-0436-01, written without dashes as 11673043601. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 11673-0436-01, the first segment (11673) is the labeler code FDA assigned to TARGET CORPORATION; the middle segment (0436) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by TARGET CORPORATION. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
TARGET CORPORATION is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 15 words

Uses cures most jock itch relieves itching, burning, crackling, and scaling which accompany this condition

⏱️ Dosage and Administration 63 words

Directions adults and children 12 years and older: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying apply once a day to affected skin for 2 weeks or as directed by a doctor wash hands after each use children under 12 years: ask a doctor

⚠️ Warnings 76 words

Warnings For external use only Do not use on nails or scalp in or near the mouth or the eyes for vaginal yeast infections When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water. Stop use and ask a doctor if too much irritation occurs or irration gets worse. Keep out of reach of children. If swallowed, get medical help or contact a Poision Control Center right away.

📦 Storage and Handling 24 words

Other Information do not use if seal on tube is broken or not visible store between 20° to 25° C (68° to 77° F)

🧪 Active Ingredient 3 words

Butenafine Hydrochloride 1%

🧪 Inactive Ingredients 24 words

Benzyl Alcohol, Cetyl Alcohol, Glycerin, Glyceryl Monostearate SE, Polyoxyethylene (23) Cetyl Ether, Propylene Glycol Dicaprylate, Purified Water, Sodium Benzoate, Stearic Acid, Trolamine, White Petrolatum.

🎯 Purpose 1 words

Antifungal

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.